Breast Cancer Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Drug, Oncology, Biopsy Device, Biomarker, Pharmaceutical, Healthcare, Radiological Equipment, Clinical Trial, Diagnostic Test, Mammography, Medical, Molecular Diagnostic, Antibody, Biochip, Breast Cancer Therapeutics, Cancer Diagnostic, Genetic, Injector, Rnai.


 
1-10 of 95 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

HER-2 Positive Breast Cancer Market in the US 2015-2019

HER-2 Positive Breast Cancer Market in the US 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in ...

A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

A Competitive Analysis of the Global Breast Cancer Therapeutics Market : A New Class of Targeted Therapeutics Offers Novel Treatment Modalities to Treat Difficult Breast Cancers

  • $ 5 000
  • Industry report
  • March 2015
  • by Frost & Sullivan

Executive Summary •The global breast cancer therapeutics market is divided into x segments: hormonal therapy, targeted therapy, chemotherapy, and other therapy (for example, novel drugs in development). ...

Global HER-2 Positive Breast Cancer Market 2015-2019

Global HER-2 Positive Breast Cancer Market 2015-2019

  • $ 3 000
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in ...

Breast Cancer Partnering 2010-2015

Breast Cancer Partnering 2010-2015

  • $ 1 795
  • Industry report
  • March 2015
  • by Currentpartnering

The Breast Cancer Partnering 2010-2015 report provides understanding and access to the breast Cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in breast ...

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report ...

Breast Cancer Drug Pathway Analyzer 2015

Breast Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 567 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

Breast Cancer Drug Pipeline Update 2015

Breast Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

About 11 000 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • February 2013
    230 pages
  • Cancer  

    Oncology  

    Breast Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.